Bryan, Garnier & Co continues aggressive growth story

US investment bank Brocair Partners combines with European growth investment bank Bryan, Garnier & Co

[Paris, New York]2 December 2019. Today, Bryan, Garnier & Co announces that Brocair Partners is joining forces with the bank.

Brocair Partners will operate under the Bryan, Garnier & Co brand with Managing Partner Gregg Blake joining Bryan, Garnier & Co as a partner focused on healthcare M&A and Brocair’s William Pay as a managing director focused on China and East Asia. Brocair’s team will be fully integrated with Bryan, Garnier & Co’s existing investment banking professionals across its New York, London, Paris, Munich, Stockholm, Oslo, Reykjavik and Palo Alto offices. With a 23 person-strong international healthcare team, Bryan, Garnier & Co’s unmatched European healthcare investment banking business will be augmented with a deeper presence globally.

Brocair has conducted cross-border healthcare M&A transactions in Switzerland, France, Ireland, the UK, Sweden, Germany, India and the US over the past 15 years, and is considered a thought leader in many healthcare subsectors. It recently advised Enköping, Sweden-based Lifco AB (OM:LIFCO B) on its acquisition of certain dental product assets of Physics Forceps, based in Detroit, and advised St. Louis-based Lee Biosolutions on its sale to Medix Biochemica, based in Espoo, Finland.

The combination provides a strong foothold for the firm to expand its leading European Life-Sciences practice in North America and Asia.

Olivier Garnier, Co-founder and Managing Partner of Bryan, Garnier & Co comments: “Bryan, Garnier & Co is an independent partnership that combines highly experienced, entrepreneur-minded investment banking professionals with the services and expertise of a top-tier investment bank. The deep healthcare expertise at Brocair will provide a strong driver to accelerate Bryan, Garnier & Co’s development in the sector.”

“We are very pleased to be teaming up with Bryan, Garnier & Co, to expand our collective footprint” says Gregg Blake, Managing Partner at Brocair Partners. “There are many synergies between our firms with deep coverage in Western Europe and the Nordics, as well as North America and Asia. Joining forces with Bryan, Garnier & Co’s robust healthcare and ECM platform will bring significantly more capabilities to bear for our clients worldwide.”

About Brocair Partners

Brocair Partners, founded in 2004, provides financial advice to businesses serving the healthcare, wellness, and pharmaceutical industries. Brocair provides mergers & acquisitions, corporate finance, and strategic advisory services to companies worldwide, and has deep expertise in cross-border transactions, with recent completed transactions in Sweden, Finland, Switzerland, France, the UK, Ireland, and India, as well as the United States.

(www.brocair.com)

About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the US. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Stockholm, Oslo, Reykjavik as well as New York and Palo Alto. The firm is a member of the London Stock Exchange.

(www.bryangarnier.com)


Healthcare market update - October 2019

Concentration in VC funding and lively private placement activity are two of the notable trends picked out in our overview of healthcare finance and developments for September.

Click here to download the report >>